This page shows you the latest news items in this category. This is page number 14.

Total 127760 results found since Jan 2013.

‘Theory of all matter’ physicists among 2023 Breakthrough prize winners
Immunologists behind pioneering cancer therapy also among recipients of most lucrative prize in scienceTwo physicists who played a key role in advancing a theory that describes the basis of all matter and a pair of immunologists who developed a pioneering cancer therapy that is currently being investigated as a treatment for autoimmune disease are among the winners of the most lucrative prize in science.Founded in 2012, the Breakthrough prize is the world ’s largest international science prize, with the winners of the five main awards – three in life sciences, one in fundamental physics, and one in mathematics – each...
Source: Guardian Unlimited Science - September 14, 2023 Category: Science Authors: Linda Geddes Science correspondent Tags: Science prizes Medical research Cancer Physics Source Type: news

Low Uptake in Nondrug Treatment for Low Back Pain With OUD Low Uptake in Nondrug Treatment for Low Back Pain With OUD
For chronic low back pain comorbid with opioid abuse, physical therapy and chiropractic care are widely recommended, yet vastly underutilized, especially in racial and ethnic minority groups.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - September 14, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Acubalance Wellness Centre Celebrates 18 Years of Excellence with Best of Vancouver 2023
This award highlights their dedication to providing high-quality integrative care. Acubalance has consistently earned this distinction for its Acupuncture and Naturopathic clinic for 18 years. They are renowned for their innovative approach to fertility treatment, including pioneering...
Source: PRWeb: Medical Pharmaceuticals - September 14, 2023 Category: Pharmaceuticals Tags: MAT AWD Source Type: news

Temporomandibular Joint (TMJ) Disorders
cgk18@duke.eduThu, 09/14/2023 - 12:49 Treatment PageTemporomandibular Joint (TMJ) Disorders Order Providers ManuallyAurelio A. Alonso, DDS, PhD, MSDaniela Vivaldi, DDSJake Awruch, PT, DPT, OCS, FAAOMPTCallie B. Beasley, PT, DPTJennifer Bent, FAAOMPT, MPT, OCSJennifer L. Davis, DPT, Cert.MDT, MS, OCSToya M. Hart, DPT, OCS, COMT, MSPT, PTBrendan Higgins, PT, DPTAmanda LeMarier, DPT, OCS, FAAOMPT, PT, Cert.DNStephanie M. Palacios, PT, DPT, NCSTroy R. Phillips, COMT, PTDana Pierson, MS, PTKathryn D. Walker, MPTPatrick T. Ward, DPT, FAAOMPT, OCS, PTDimitri Putilin, PhD
Source: dukehealth.org: Health Tips - September 14, 2023 Category: Primary Care Authors: cgk18 at duke.edu Source Type: news

Surgery May Worsen Pleural Mesothelioma Survival Outcomes Surgery May Worsen Pleural Mesothelioma Survival Outcomes
There has been little improvement in systemic treatment of early-stage, resectable mesothelioma.MDedge News
Source: Medscape Medical News Headlines - September 14, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

MDMA Therapy for PTSD Inches Closer to U.S. Approval
Results of a new study may offer regulators enough evidence to allow the psychedelic, also known as Ecstasy, to be considered for use as a PTSD treatment.
Source: NYT Health - September 14, 2023 Category: Consumer Health News Authors: Rachel Nuwer Tags: Research Post-Traumatic Stress Disorder Therapy and Rehabilitation Drugs (Pharmaceuticals) Ecstasy (Drug) Psychiatry and Psychiatrists Drug Enforcement Administration Food and Drug Administration MAPS Public Benefit Corporation your-feed Source Type: news

Cancer patients missing out on breakthrough treatment as UK falls 'behind the pack', experts warn
Cancer experts told MPs today that pharmaceutical companies are shying away from launching new clinical trials in the UK for the first time due to being 'mired' in paperwork.
Source: the Mail online | Health - September 14, 2023 Category: Consumer Health News Source Type: news

Interventions Can Increase Adjuvant Endocrine Treatment Adherence
THURSDAY, Sept. 14, 2023 -- Lowering medication costs and some psychosocial and reminder interventions show the most promise for promoting adjuvant endocrine therapy (AET) adherence in breast cancer survivors, according to a review published online...
Source: Drugs.com - Pharma News - September 14, 2023 Category: Pharmaceuticals Source Type: news

MDMA Therapy for PTSD Inches Closer to U.S. Approval
MDMA pills used in a study on the drug’s effectiveness as a treatment for post-traumatic stress disorder in veterans. Results of a new study may offer regulators enough evidence to allow the psychedelic, also known as Ecstasy, to be considered for use as a PTSD treatment. MDMA-assisted therapy…#mdma #ecstasy #berrayazarklosinski #naturemedicine #stephenxenakis #molly #schedule1 #rickdoblin #maps #mapspbc
Source: Reuters: Health - September 14, 2023 Category: Consumer Health News Source Type: news

US considering seeking access to more Philippine bases, admiral says
[1/2] Admiral John C. Aquilino, Commander of the United States Indo-Pacific Command speaks at the IISS Special Lecture in Singapore March 16, 2023. REUTERS/Caroline Chia/File Photo Acquire Licensing Rights MANILA, Sept 14 (Reuters) - The U.S. military could be granted access to more bases in the…#johncaquilino #iissspeciallecture #singapore #philippines #usindopacific #taiwan #spratlyislands #southchinasea #manila #beijing
Source: Reuters: Health - September 14, 2023 Category: Consumer Health News Source Type: news

AI startup Carenostics raises $5 million in Seed funding led by M13 to transform healthcare through earlier diagnosis and treatment of chronic disease patients
Carenostics brings together the first team to ever deploy AI at 1,000+ health systems to now tackle the underdiagnosis, undertreatment, and health inequities of chronic disease. NEW YORK, Sept. 14, 2023 /PRNewswire-PRWeb/ -- Carenostics, a pioneering healthcare AI startup tackling...
Source: PRWeb: Medical Pharmaceuticals - September 14, 2023 Category: Pharmaceuticals Tags: VEN FNC Source Type: news

Philips Sonicare Partners With Sydney Leroux To Motivate Listeners ' Wellness Routines Through Spotify
 The in-app experience provides personalized, motivational voiceovers from Leroux and other special guests to give an extra push when needed most.STAMFORD, Conn., Sept. 14, 2023 /PRNewswire/ -- Philips Sonicare, the #1 dental professional-recommended sonic toothbrush brand worldwide, is on a mission to help people make the most of their routines. The oral healthcare brand is teaming up with powerhouses Spotify, one of the world ' s most popular audio streaming platforms, and professional soccer player and gold medalist Sydney Leroux to motivate listeners to make positive, healthy changes in their d...
Source: Dental Technology Blog - September 14, 2023 Category: Dentistry Source Type: news

2024 Breakthrough Prizes Announced: Cystic Fibrosis Pioneers Awarded $3 Million
Researchers at Vertex Pharmaceuticals were honored for their revolutionary work in the treatment of genetic disorder, along with other scientists in biology, physics and mathematics.
Source: Forbes.com Healthcare News - September 14, 2023 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare Billionaires /worlds-billionaires Editors' Pick editors-pick technology alexknappblog premium Source Type: news

NICE to recommend rimegepant as first acute migraine treatment
NICE has approved rimegepant as the first treatment for acute migraine, in draft guidance published today. Around 13,000 could benefit from rimegepant (Vydura, Pfizer), said NICE after signing off its use in adults who have tried at least two triptans but they did not work well enough. It can also be used for those in... Read moreThe post NICE to recommend rimegepant as first acute migraine treatment appeared first on Nursing in Practice.
Source: Nursing in Practice - September 14, 2023 Category: Nursing Authors: Wiliam Hunter Tags: Clinical Latest news Women's health Source Type: news